Position in PTCT
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$29,388,829
+$17,221,633 QoQ
Shares Held
431,364
+169.3% QoQ
Ownership
5.20%
of shares outstanding
% of Portfolio
3.05%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2024
7 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in PTCT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Parkman Healthcare Partners LLC holds $362,342,788 across 36 Biotechnology names. PTCT ranks #2 (8.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | KALV |
KalVista Pharmaceuticals, Inc.
|
1,835,506 | $36,948,735 | |
| 2 | PTCT |
Ptc Therapeutics, Inc.
This page
|
431,364 | $29,388,829 | |
| 3 | XENE |
Xenon Pharmaceuticals Inc.
|
497,035 | $28,902,585 | |
| 4 | RCUS |
Arcus Biosciences, Inc.
|
1,207,274 | $26,077,118 | |
| 5 | MBX |
MBX Biosciences, Inc.
|
800,037 | $23,881,104 | |
| 6 | SNDX |
Syndax Pharmaceuticals Inc
|
901,511 | $21,059,296 | |
| 7 | EYPT |
EyePoint, Inc.
|
1,354,800 | $17,463,372 | |
| 8 | AGIO |
Agios Pharmaceuticals, Inc.
|
403,525 | $13,651,250 |
All Filings in PTCT
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $29,388,829 | 431,364 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $12,167,196 | 160,179 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $12,419,017 | 202,363 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $8,871,444 | 181,643 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $14,284,801 | 280,314 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $8,006,391 | 177,368 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $7,234,500 | 195,000 | Shares | Sole | 2024-11-14 | |
| No filing history on record for this holder in this stock. | ||||||